Patients considering intralymphatic immunotherapy often want to understand what the procedure involves. Having a clear understanding of the process can help reduce uncertainty and support informed decision-making.

Intralymphatic immunotherapy (ILIT) is performed in a medical setting under physician supervision using ultrasound guidance.

Step 1: Comprehensive Medical Evaluation

Before treatment is considered, patients undergo a detailed evaluation that includes a review of allergy history and symptoms, assessment of allergy testing results, discussion of prior treatments and response, and a review of potential risks and alternatives.

ILIT is offered only when it is medically appropriate.

Step 2: Ultrasound-Guided Injection

During treatment, superficial lymph nodes are identified using real-time ultrasound. Ultrasound guidance confirms accurate needle placement, and allergen extract is delivered precisely into the lymph node. We use the tiniest needle possible to minimize discomfort.

This approach allows for consistent delivery while minimizing unnecessary tissue exposure.

Step 3: Monitoring and Follow-Up

After each injection, patients are observed for an hour in the waiting room to ensure safety and comfort.

Safety Considerations

As with all forms of allergen immunotherapy, intralymphatic immunotherapy carries potential risks. These risks are reviewed in detail prior to treatment so patients can make informed decisions.